As of Apr 23, 2025, the Johnson & Johnson stock's PE ratio is 17.15. This takes into account the latest EPS of $9.06 and stock price of $155.38. The PE ratio marks a decrease of 13% from its last 4 quarters average of 19.8.
The PE ratio of Johnson & Johnson has averaged 45.09 over the last ten years. The current P/E ratio of 17.15 is 62% lower than the historical average. Looking back at the last ten years, JNJ's PE ratio peaked in the Dec 2017 quarter at 291.08, when the price was $139.72 and the EPS was $0.48. The lowest point was in the Jun 2024 quarter, when it reached 9.6 with a price of $146.16 and an EPS of $15.23.
Maximum annual increase: 1,426.38% in 2017
Maximum annual decrease: -92.33% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 24.84 | 120.02% | $145.05 | $5.84 |
2023 | 11.29 | -56.34% | $156.74 | $13.88 |
2023 | 25.86 | 19.89% | $176.65 | $6.83 |
2022 | 21.57 | -23.37% | $171.07 | $7.93 |
2021 | 28.15 | 10.48% | $157.38 | $5.59 |
2019 | 25.48 | 14.11% | $145.75 | $5.72 |
2018 | 22.33 | -92.33% | $127.27 | $5.7 |
2017 | 291.08 | 1,426.38% | $139.72 | $0.48 |
2017 | 19.07 | 3.25% | $115.21 | $6.04 |
2016 | 18.47 | 1.99% | $102.72 | $5.56 |
2014 | 18.11 | -3.52% | $105.06 | $5.8 |
2013 | 18.77 | 6.47% | $92.35 | $4.92 |
2012 | 17.63 | -4.86% | $69.48 | $3.94 |
2012 | 18.53 | 45.33% | $65.58 | $3.54 |
2011 | 12.75 | -11.89% | $61.85 | $4.85 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 18.07 | -27.25% | $163.71 | $9.06 |
Dec 2024 | 24.84 | -7.21% | $145.05 | $5.84 |
Sep 2024 | 26.77 | 178.85% | $161.4 | $6.03 |
Jun 2024 | 9.6 | -7.43% | $146.16 | $15.23 |
Mar 2024 | 10.37 | -8.15% | $158.19 | $15.26 |
Dec 2023 | 11.29 | -1.31% | $156.74 | $13.88 |
Oct 2023 | 11.44 | -65.51% | $155.75 | $13.61 |
Jul 2023 | 33.17 | 3.59% | $165.52 | $4.99 |
Apr 2023 | 32.02 | 23.82% | $155 | $4.84 |
Jan 2023 | 25.86 | 15.55% | $176.65 | $6.83 |
Oct 2022 | 22.38 | -12.85% | $163.36 | $7.3 |
Jul 2022 | 25.68 | 8.68% | $179.52 | $6.99 |
Apr 2022 | 23.63 | 9.55% | $178.19 | $7.54 |
Jan 2022 | 21.57 | -8.87% | $171.07 | $7.93 |
Oct 2021 | 23.67 | -5.58% | $160.47 | $6.78 |
JNJ's current PE ratio is lower than its 3, 5 and 10-year averages.
In comparison to its peers LLY and NVS, JNJ's PE ratio is lower, but it is higher than ABT's and MRK's. Johnson & Johnson's PE ratio is trading below the peer average of 29.17.
Stock name | PE ratio | Market cap |
---|---|---|
MRK Merck & Co Inc | 11.78 | $201.2B |
PFE Pfizer Inc | 16 | $128.79B |
ABT Abbott Laboratories | 16.95 | $225.41B |
JNJ Johnson & Johnson | 17.1 | $372.77B |
NVS Novartis AG | 18.77 | $219.43B |
MDT Medtronic plc | 25.47 | $108.13B |
SYK Stryker Corp | 45.84 | $137.49B |
LLY ELI LILLY & Co | 72.94 | $813.36B |
GILD Gilead Sciences Inc | 280.05 | $132.53B |
JNJ stock has a price to earnings ratio of 17.15 as of Apr 23, 2025.
The average PE ratio for JNJ stock over the past 3 years is 20.96.
The average PE ratio for JNJ stock over the past 5 years is 22.42.
Over the last ten years, the Dec 2017 quarter recorded the highest quarterly PE ratio at 291.08.
JNJ's price to earnings ratio is currently 62% below its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Apr 23, 2025), Johnson & Johnson's share price is $155.38. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $9.06. Therefore, Johnson & Johnson's PE ratio for today is 17.15. PE RATIO(17.15) = STOCK PRICE($155.38) / TTM EPS($9.06)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.